MedTrace Logo

StimRouter Registry Clinical Protocol

NCT03913689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2025-05-20

No results posted yet for this study

Summary

This Registry study will prospectively evaluate the long-term effectiveness, safety, and tolerability of the StimRouter Neuromodulation System, along with evaluating the technical performance of StimRouter, surgical outcomes, health-related quality of life, concomitant medical use, and subject's impression of improvement.

Conditions

  • Chronic Pain
  • Peripheral Neuropathy
  • Nervous System Diseases
  • Peripheral Nervous System Diseases
  • Peripheral Nervous System Problem
  • Peripheral Nerve Injuries
  • Peripheral Nervous

Interventions

DEVICE

StimRouter Neuromodulation System

An implantable neuromodulation device that treats chronic peripheral nerve pain.

Sponsors & Collaborators

  • Bioness Inc

    lead INDUSTRY

Principal Investigators

  • Keith McBride · Bioness Inc

  • Eric Grigsby, MD · Bioness Inc

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-26
Primary Completion
2024-03-30
Completion
2024-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03913689 on ClinicalTrials.gov